Corpus ID: 9924251

Whole body extracorporeal low flow hyperthermia in a canine model

@inproceedings{Cyr1996WholeBE,
  title={Whole body extracorporeal low flow hyperthermia in a canine model},
  author={John A. St. Cyr and Toni Kelly and Linda M. Shecterle},
  year={1996}
}
Whole body hyperthermia (WBH) has not gained significant clinical acceptance, though extensive experimentation since the early 1980's has revealed its potential merits in the treatment of various cancers, and currently WBH is in clinical feasibility trials for Acquired Immune Deficiency Syndrome (AIDS). Using a new device and methodology, could canines serve as an appropriate test model for this device and methodology? Five dogs underwent one treatment each of the 42°C whole body hyperthermia… CONTINUE READING

Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

Tables and Topics from this paper.

Citations

Publications citing this paper.

Effects on C3 and CH50 levels during and following extracorporeal whole body hyperthermia.

VIEW 3 EXCERPTS
CITES BACKGROUND & METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 11 REFERENCES

Cardiovascular and metabolic response of tumour-bearing dogs to whole body hyperthermia.

VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Does hyperthermia have a therapeutic role in HIV disease

  • LM Shecterle, JA St.Cyr
  • Minn Acad Sci
  • 1994

Does hyperthermia have a therapeutic role in HIV disease ? 1

  • LM Shecterle, JA St.Cyr
  • Minn Acad Sci
  • 1994

Extracorporeally induced total-body hyperthermia for disseminated cancer.

VIEW 2 EXCERPTS

Clinical hyperthermia and chemotherapy.

Clinical effects of total-body hyperthermia combined with anticancer chemotherapy for far-advanced gastrointestinal cancer

  • S Koga, M Maeta, N Shimzu
  • 1985
VIEW 2 EXCERPTS